Abstract:Experimental Biology and Medicine, Ahead of Print. In recent years, with the increase of air pollution, smoking, aging, and respiratory infection, the incidence rate and mortality of lung diseases are increasing annually, which has become a major hazard to human health. N6-methyladenosine (m6A) RNA methylation is the most abundant modifications in eukaryotes, and such modified RNA can be specifically recognized and combined by m6A recognition proteins and then mediate RNA splicing, maturation, enucleation, degradation, and translation. More and more studies have revealed that the m6A modification is involved in the pathogenesis and development of some diseases; however, the mechanisms of m6A in lung diseases are poorly understood. In this review, we summarize the latest progress in the biological function of m6A modifications in lung diseases and discuss the potential therapeutic and prognostic strategies. The dysregulation of global m6A levels and m6A regulators may affect the occurrence and development of asthma, chronic obstructive pulmonary disease, lung cancer, and other lung diseases through inflammation and immune function. In lung cancer, this modification has an important impact on malignant cell proliferation, migration, invasion, and drug resistance. In addition, abnormally changed m6A-modified proteins in lung cancer tissue samples and circulating tumor cells (CTCs) may be used as diagnostic and prognostic markers of lung cancer. Models composed of multiple m6A regulators can be used to evaluate the risk prediction or prognosis of asthma and pulmonary fibrosis. In general, the in-depth study of m6A modifications is a frontier direction in disease research. It provides novel insights for understanding of the molecular mechanisms underlying disease occurrence, development, and drug resistance, as well as for the development of effective novel therapeutics.

Genetic regulation of m6A RNA methylation and its contribution in human complex diseases

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

The Roles of M6a RNA Modifiers in Human Cancer

Genetic Analyses Support the Contribution of Mrna N 6 -Methyladenosine (m 6 A) Modification to Human Disease Heritability

Genetic analyses support the contribution of mRNA N6-methyladenosine (m6A) modification to human disease heritability

Regulatory roles of N6-methyladenosine (m 6 A) methylation in RNA processing and non-communicable diseases

Regulation of m6Am RNA modification and its implications in human diseases

Regulatory Roles of N6-methyladenosine (m6a) Methylation in RNA Processing and Non-Communicable Diseases

Allele-specific RNA N6-methyladenosine modifications reveal functional genetic variants in human tissues

The role of m6A modification in the biological functions and diseases

m6A modification and its role in neural development and neurological diseases

The role of m6A modification in physiology and disease

Crosstalk between epitranscriptomic and epigenomic modifications and its implication in human diseases

Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases

N6-methyladenosine methyltransferases: functions, regulation, and clinical potential

Emerging role of N6-methyladenosine RNA methylation in lung diseases

The role of m6A-associated membraneless organelles in the RNA metabolism processes and human diseases

Emerging Role of M6a RNA Methylation in Nutritional Physiology and Metabolism